Psychiatry

Back to articles

FDA Approves GHB Under Restricted Distribution Scheme

KEY POINT

Sodium oxybate (gamma hydroxybutyrate, GHB; Xyrem—Orphan Medical), a known drug of abuse, has been approved by FDA to treat cataplexy, a sudden loss of muscle tone associated with narcolepsy.